BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 27575718)

  • 1. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
    Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
    ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Lan G; Tang H; Pelizzari C; Fu YX; Spiotto MT; Weichselbaum RR; Lin W
    Nat Biomed Eng; 2018 Aug; 2(8):600-610. PubMed ID: 31015630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeted porphyrin-based metal-organic framework for photodynamic and checkpoint blockade immunotherapy.
    Liu Y; Zou B; Yang K; Jiao L; Zhao H; Bai P; Tian Y; Zhang R
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113965. PubMed ID: 38772084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Affinity of Chlorin e6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy.
    Xu J; Yu S; Wang X; Qian Y; Wu W; Zhang S; Zheng B; Wei G; Gao S; Cao Z; Fu W; Xiao Z; Lu W
    ACS Nano; 2019 Sep; 13(9):10242-10260. PubMed ID: 31397999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale Metal-Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy.
    Lan G; Ni K; Xu Z; Veroneau SS; Song Y; Lin W
    J Am Chem Soc; 2018 May; 140(17):5670-5673. PubMed ID: 29665677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
    Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y; Xie J
    J Nanobiotechnology; 2021 Jun; 19(1):182. PubMed ID: 34127005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
    Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
    Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy.
    Ni K; Aung T; Li S; Fatuzzo N; Liang X; Lin W
    Chem; 2019 Jul; 5(7):1892-1913. PubMed ID: 31384694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
    Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
    Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
    Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
    Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy.
    Ni K; Lan G; Chan C; Quigley B; Lu K; Aung T; Guo N; La Riviere P; Weichselbaum RR; Lin W
    Nat Commun; 2018 Jun; 9(1):2351. PubMed ID: 29907739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy.
    Ni K; Luo T; Lan G; Culbert A; Song Y; Wu T; Jiang X; Lin W
    Angew Chem Int Ed Engl; 2020 Jan; 59(3):1108-1112. PubMed ID: 31642163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer.
    Shi J; Liu C; Luo S; Cao T; Lin B; Zhou M; Zhang X; Wang S; Zheng T; Li X
    Cell Immunol; 2021 Aug; 366():104384. PubMed ID: 34182334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A versatile nanoplatform based on multivariate porphyrinic metal-organic frameworks for catalytic cascade-enhanced photodynamic therapy.
    Ren SZ; Zhu XH; Wang B; Liu M; Li SK; Yang YS; An H; Zhu HL
    J Mater Chem B; 2021 Jun; 9(23):4678-4689. PubMed ID: 34075929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumor microenvironment responsive biodegradable CaCO
    Liu Y; Pan Y; Cao W; Xia F; Liu B; Niu J; Alfranca G; Sun X; Ma L; de la Fuente JM; Song J; Ni J; Cui D
    Theranostics; 2019; 9(23):6867-6884. PubMed ID: 31660074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.